Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case report

Fig. 3

PET-CT images showing visible regression of the multiple metastases after 16 weeks of crizotinib monocherapy. a Follow-up PET-CT image taken on January 10, 2017 at 3 months after surgery showed hypermetabolic metastases in multiple regions, before the start of cizotinib treatment. b Follow-up PET-CT images taken on May 19, 2017 at 4 months after initiation of crizotinib showed near-CCR

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us